J-1048

J-1048: sourced facts only. name: "To develop the candidate with anti-fibrotic effect, we synthesized a novel pyrazole derivative, J-1048." [1] target: "Our findings demonstrated that a novel small molecule ALK5 inhibitor, J-1048, exhibited strong potential as a clinical therapeutic candidate" [1] developer: "Key Laboratory of Traditional Chinese Korean Medicine Research (Yanbian University) of State Ethnic Affairs Commission, Colle" [1] stage: "J-1048 inhibited TAA-induced liver fibrosis in mice by explicitly blocking the TGF-β/Smad signaling pathway." [1] modality: "Our findings demonstrated that a novel small molecule ALK5 inhibitor, J-1048, exhibited strong potential as a clinical therapeutic candidate" [1]